Pharma Sectors Report for the week (16-20.07.2012) Stocks of pharmaceutical companies are seen trading in a range-bound manner next week. However, investors will eye Dr Reddy's Laboratories Ltd's Apr-Jun result to be detailed on Thursday. Sequentially, the company's net profit is seen rising 3% while its net sales are likely to fall by 4% over the Jan-Mar quarter.
In the next few trading sessions, shares of Cipla Ltd are seen trading with a positive bias and investors with a long horizon may enter the stock at around 332 rupees, with a target of 355 rupees. Near-term support for the stock is seen at 325 rupees. Apart from stock-specific movement, the sector will take cues from the broader market in the next five trading sessions. India's wholesale price inflation for June, which will be detailed on Monday, is likely to set the mood for the domestic indices. Investors will also eye the Apr-Jun earnings of companies. By RUPEE DESK [email protected] -- You received this message because you are subscribed to the Google Groups "Kences1- Rupeedesk" group. To post to this group, send email to [email protected]. To unsubscribe from this group, send email to [email protected]. For more options, visit this group at http://groups.google.com/group/kences1?hl=en.
